Fifth Third Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Buy
759
+9
+1% +$4.15K 0.01% 575
2026
Q1
$360K Buy
750
+11
+1% +$5.63K 0.01% 535
2025
Q4
$415K Buy
739
+2
+0.3% +$1.14K 0.01% 448
2025
Q3
$379K Buy
737
+19
+3% +$8.29K 0.01% 475
2025
Q2
$225K Buy
718
+2
+0.3% +$600 0.01% 660
2025
Q1
$218K Sell
716
-33
-4% -$11.1K 0.01% 640
2024
Q4
$249K Sell
749
-30
-4% -$10.2K 0.01% 590
2024
Q3
$260K Buy
779
+70
+10% +$26.6K 0.02% 532
2024
Q2
$292K Buy
+709
New +$281K 0.02% 421

Other funds holding MEDP

Fifth Third Wealth Advisors's MEDP Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Medpace (MEDP) stake by 1.2% in Q2 2026, buying an estimated $4.15K and bringing the position to 759 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #575.

Fifth Third Wealth Advisors first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $415K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Fifth Third Wealth Advisors held 759 shares of Medpace worth $402K as of Q2 2026.
  • Fifth Third Wealth Advisors bought 9 Medpace shares in Q2 2026, an estimated $4.15K.
  • Medpace made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #575 holding.
  • Fifth Third Wealth Advisors first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Fifth Third Wealth Advisors's Medpace position peaked at $415K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.